Prostaglandin E2 Inhibits Fibroblast to Myofibroblast Transition via E. Prostanoid Receptor 2 Signaling and Cyclic Adenosine Monophosphate Elevation

American Journal of Respiratory Cell and Molecular Biology

Volumn 29, Issue 5, 2003, Pages 537-544

  Kolodsick, Jill E ^a   Peters Golden, Marc ^a   Larios, José ^a   Toews, Galen B ^a   Thannickal, Victor J ^a   Moore, Bethany B ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENYLATE CYCLASE; ALPHA ACTIN; ALPHA SMOOTH MUSCLE ACTIN; BUTAPROST; COLLAGEN TYPE 1; CYCLIC AMP; E PROSTANOID RECEPTOR 2; FORSKOLIN; PROSTAGLANDIN E RECEPTOR; PROSTAGLANDIN E2; PROSTANOID RECEPTOR; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CELL TRANSFORMATION; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; FETUS; HUMAN; HUMAN CELL; LUNG ALVEOLUS; LUNG FIBROBLAST; LUNG FIBROSIS; MYOFIBROBLAST; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; CELL DIFFERENTIATION; FIBROBLAST; METABOLISM; PHYSIOLOGY;

CELL DIFFERENTIATION; CYCLIC AMP; DINOPROSTONE; FIBROBLASTS; FORSKOLIN; HUMANS; RECEPTORS, PROSTAGLANDIN E;

EID: 0242319836     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2002-0243OC     Document Type: Article

References (36)

1. Strieter, R. M. 2001. Mechanisms of pulmonary fibrosis: conference summary. Chest 120 (1 Suppl):77S-85S.
2. Selman, M., T. E. King, and A. Pardo. 2001. Idiopathic pulmonary fibrosis: prevailing and evolving hypotheses about its pathogenesis and implications for therapy. Ann. Intern. Med. 134:136-151.
3. Adler, K. B., J. E. Craighead, N. V. Vallyathan, and J. N. Evans. 1981. Actin-containing cells in human pulmonary fibrosis. Am. J. Pathol. 102:427-437.
4. Mitchell, J., J. Woodcock-Mitchell, S. Reynolds, R. Low, K. Leslie, K. Adler, G. Gabbiani, and O. Skalli. 1989. Alpha-smooth muscle actin in parenchymal cells of bleomycin-injured rat lung. Lab. Invest. 60:643-650.
5. Zhang, H. Y., M. Gharaee-Kermani, and S. H. Phan. 1997. Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1beta. J. Immunol. 158:1392-1399.
6. Zhang, H. Y., M. Gharaee-Kermani, K. Zhang, S. Karmiol, and S. H. Phan. 1996. Lung fibroblast alpha-smooth muscle actin expression and contractile phenotype in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 148:527-537.
7. Desmouliere, A., and G. Gabbiani. 1995. Myofibroblast differentiation during fibrosis. Exp. Nephrol. 3:134-139.
8. Zhang, K., M. D. Rekhter, D. Gordon, and S. H. Phan. 1994. Myofibroblasts and their role in lung collagen gene expression during pulmonary fibrosis: a combined immunohistochemical and in situ hybridization study. Am. J. Pathol. 145:114-125.
9. Zhang, K., K. C. Flanders, and S. H. Phan. 1995. Cellular localization of transforming growth factor-beta expression in bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 147:352-361.
10. Zhang, K., M. Gharaee-Kermani, M. L. Jones, J. S. Warren, and S. H. Phan. 1994. Lung monocyte chemoattractant protein-1 gene expression in bleomycin-induced pulmonary fibrosis. J. Immunol. 153:4733-4741.
11. Phan, S. H. 1996. Role of the myofibroblast in pulmonary fibrosis. Kidney Int. Suppl. 54:S46-S48.
12. Desmouliere, A. 1995. Factors influencing myofibroblast differentiation during wound healing and fibrosis. Cell Biol. Int. 19:471-476.
13. Desmouliere, A., A. Geinoz, F. Gabbiani, and G. Gabbiani. 1993. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J. Cell Biol. 122:103-111.
14. Hansson, G. K., M. Hellstrand, L. Rymo, L. Rubbia, and G. Gabbiani. 1989. Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells. J. Exp. Med. 170:1595-1608.
15. Desmouliere, A., L. Rubbia-Brandt, A. Abdiu, T. Walz, A. Macieira-Coelho, and G. Gabbiani. 1992. Alpha-smooth muscle actin is expressed in a subpopulation of cultured and cloned fibroblasts and is modulated by gamma-interferon. Exp. Cell Res. 201:64-73.
16. Bitterman, P., N. Wewers, S. Rennard, S. Adelberg, and R. Cyrstal. 1986. Modulation of alveolar macrophage-driven fibroblast proliferation by alternative macrophage mediators. J. Clin. Invest. 77:700-708.
17. Elias, J., M. Rossman, R. Zurier, and R. Daniele. 1985. Human alveolar macrophage inhibition of lung fibroblast growth: a prostaglandin-dependent process. Am. Rev. Respir. Dis. 131:94-99.
18. Clark, J. G., K. M. Kostal, and B. A. Marino. 1982. Modulation of collagen production following bleomycin-induced pulmonary fibrosis in hamsters: presence of a factor in lung that increases fibroblast prostaglandin E2 and cAMP and suppresses fibroblast proliferation and collagen production. J. Biol. Chem. 257:8098-8105.
19. Fine, A., C. F. Poliks, L. P. Donahue, B. D. Smith, and R. H. Goldstein. 1989. The differential effect of prostaglandin E2 on transforming growth factor-beta and insulin-induced collagen formation in lung fibroblasts. J. Biol. Chem. 264:16988-16991.
20. Borok, Z., A. Gillissen, R. Buhl, R. F. Hoyt, R. C. Hubbard, T. Ozaki, S. I. Rennard, and R. G. Crystal. 1991. Augmentation of functional prostaglandin E levels on the respiratory epithelial surface by aerosol administration of prostaglandin E. Am. Rev. Respir. Dis. 144:1080-1084.
21. Vancheri, C., M. A. Sortino, V. Tomaselli, C. Mastruzzo, F. Condorelli, G. Bellistri, M. P. Pistorio, P. L. Canonico, and N. Crimi. 2000. Different expression of TNF-α receptors and prostaglandin E(2) production in normal and fibrotic lung fibroblasts: potential implications for the evolution of the inflammatory process. Am. J. Respir. Cell Mol. Biol. 22:628-634.
22. Wilborn, J., L. J. Crofford, M. D. Burdick, S. L. Kunkel, R. M. Strieter, and M. Peters-Golden. 1995. Cultured lung fibroblasts isolated from patients with idiopathic pulmonary fibrosis have a diminished capacity to synthesize prostaglandin E2 and to express cyclooxygenase-2. J. Clin. Invest. 95:1861-1868.
23. Moore, B. B., M. Peters-Golden, P. J. Christensen, V. Lama, W. A. Kuziel, R. Paine, III. and G. B. Toews. 2003. Alveolar epithelial cell inhibition of fibroblast proliferation is regulated by MCP-1/CCR2 and mediated by PGE2. Am. J. Physiol. Lung Cell. Mol. Physiol. 284:L342-L349.
24. Nichols, W. W., D. G. Murphy, V. J. Cristofalo, L. H. Toji, A. E. Greene, and S. A. Dwight. 1977. Characterization of a new human diploid cell strain, IMR-90. Science 196:60-63.
25. Saltzman, L. E., J. Moss, R. A. Berg, B. Hom, and R. G. Crystal. 1982. Modulation of collagen production by fibroblasts: effects of chronic exposure to agonists that increase intracellular cyclic AMP. Biochem. J. 204:25-30.
26. Choung, J., L. Taylor, K. Thomas, X. Zhou, H. Kagan, X. Yang, and P. Polgar. 1998. Role of EP2 receptors and cAMP in prostaglandin E2 regulated expression of type I collagen alpha1, lysyl oxidase, and cyclooxygenase-1 genes in human embryo lung fibroblasts. J. Cell. Biochem. 71:254-263.
27. Shimizu, E., Y. Kobayashi, Y. Oki, T. Kawasaki, T. Yoshimi, and H. Nakamura. 1999. OPC-13013, a cyclic nucleotide phosphodiesterase type III, inhibitor, inhibits cell proliferation and transdifferentiation of cultured rat hepatic stellate cells. Life Sci. 64:2081-2088.
28. Vyalov, S. L., G. Gabbiani, and Y. Kapanci. 1993. Rat alveolar myofibroblasts acquire alpha-smooth muscle actin expression during bleomycin-induced pulmonary fibrosis. Am. J. Pathol. 143:1754-1765.
29. Khalil, N., O. Bereznay, M. Sporn, and A. H. Greenberg. 1989. Macrophage production of transforming growth factor beta and fibroblast collagen synthesis in chronic pulmonary inflammation. J. Exp. Med. 170:727-737.
30. Desmouliere, A., L. Rubbia-Brandt, G. Grau, and G. Gabbiani. 1992. Heparin induces alpha-smooth muscle actin expression in cultured fibroblasts and in granulation tissue myofibroblasts. Lab. Invest. 67:716-726.
31. Masamune, A., K. Kikuta, M. Satoh, Y. Sakai, A. Satoh, and T. Shimosegawa. 2002. Ligands of peroxisome proliferator-activated receptor-gamma block activation of pancreatic stellate cells. J. Biol. Chem. 277:141-147.
32. Ludwicka, A., T. Ohba, M. Trojanowska, A. Yamakage, C. Strange, E. A. Smith, E. C. Leroy, S. Sutherland, and R. M. Silver. 1995. Elevated levels of platelet derived growth factor and transforming growth factor-beta 1 in bronchoalveolar lavage fluid from patients with scleroderma. J. Rheumatol. 22:1876-1883.
33. Korn, J. H. 1983. Fibroblast prostaglandin E2 synthesis: persistence of an abnormal phenotype after short-term exposure to mononuclear cell products. J. Clin. Invest. 71:1240-1246.
34. Polgar, P., L. Taylor, and D. Downing. 1979. Unsaturated fatty acid effect on cyclic AMP levels in human embryo lung fibroblasts. Prostaglandins 18:43-52.
35. Keerthisingam, C. B., R. G. Jenkins, N. K. Harrison, N. A. Hernandez-Rodriguez, H. Booth, G. J. Laurent, S. L. Hart, M. L. Foster, and R. J. McAnulty. 2001. Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. Am. J. Pathol. 158:1411-1422.
36. Moore, B., M. Coffey, P. Christensen, S. Sitterding, R. Ngan, R. Mc, S. Donald, M. Phare, R. P. I. I. I. Peters-Golden, and G. Toews. 2000. GM-CSF regulates bleomycin-induced pulmonary fibrosis via a prostaglandin E2 mechanism. J. Immunol. 165:4032-4039.